Page 4 - Drugs

Australian cricketer Stuart MacGill spared jail time over supplying cocaine

Former Australian Test bowler Stuart MacGill was spared jail time and given a community service order when he appeared in court on Friday for sentencing over supplying cocaine. MacGill was convicted of supplying drugs for a deal between his regular supplier and his brother-in-law in April 2021. He appeared at Downing Centre District Court where a statement from former Test captain Steve Waugh supported his former colleague. MacGill was sentenced to an intensive corrections order of one year and 10 months. MacGill must complete 495 hours of community service work and undergo drug testing as part of the order, in lieu of a prison term. The former legspinner, who began using cocaine after he retired from cricket, was found guilty in March of supplying an indictable quantity of the drug. A jury determined the 54-year-old MacGill knew about the deal between his regular dealer and his brother-in-law but was oblivious to the fact a one-kilogram (2.2-pound) brick was changing hands. He was

CDSCO revises export NOC rules for new drugs; sets one-year validity

New CDSCO rules set one-year validity for export NOCs, fix seven-day timeline, and simplify process for unapproved and approved drugs meant solely for export

NPPA fixes retail prices of 84 drugs, including empagliflozin combos

The NPPA has fixed retail prices for 84 drug formulations, including 36 combinations of off-patent diabetes drug empagliflozin, after a steep drop in prices

India's pharma market grows 7.8% in April, led by chronic therapies

Chronic therapies and price increases drove 7.8 per cent growth in India's pharma market in April 2025, with cardiac and gastrointestinal segments showing double-digit value gains

Trump's 'Make in America' push: Indian drug cos in no rush to make US shift

Pharma industry veteran said that the US wanting to encourage local production is a very natural thing to do

Punjab targets to become drug-free by May 31; DGP asks officers to lead

Ending drugs trafficking by May 31: that's the ambitious target Punjab Police has set for itself with the force's chief directing all senior officers to firm up plans to cut narcotic supply lines effectively. Punjab Director General of Police (DGP) Gaurav Yadav took the carrot and stick approach to ensure the deadline is met. He announced that Senior Superintendents of Police (SSPs) and Commissioners of Police (CPs) would be rewarded for their "good work" and held accountable if their performance was not up to the mark. Addressing reporters here, Yadav said Punjab will be made a drug-free state in the sense that the availability of narcotics on the streets is fully culled. The DGP emphasised the decision was a well-considered one and arrived at after Chief Minister Bhagwant Mann reviewed the ongoing anti-drug drive "Yudh Nashyan Virudh". "We have asked all field police officers -- the SSPs and CPs -- to lead this campaign from the front so that Punjab can be made drugs-free in the

Booster dose: India inches closer to regulatory framework for OTC drugs

DTAB has accepted sub-panel recommendation on OTC drugs list

Will doorstep medicine delivery end? Govt panel set to take a call soon

India's Drugs Technical Advisory Board will review the continuation of home medicine delivery, following objections from chemists' body AIOCD, which cites misuse by online platforms

Patent loss led to rise in prescriptions of new generation diabetes drugs

Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions

CDSCO flags spurious batch of Telma, 131 other drugs fail quality tests

One of the popular hypertension medication brands Telma 40 samples were found to be spurious in raids across locations

Govt restricts sale of anti-cold drug combination for children under 4 yrs

The FDC is also effective in treating symptoms like watery eyes, runny nose, sneezing and other discomforts

CDSCO halts manufacture, sale, distribution of 35 FDCs over safety concerns

The list of unapproved FDCs includes antidiabetics, antibiotics, painkillers, infertility medications and nutritional supplements

Scientists behind Ozempic and Wegovy win $3-million Breakthrough Prize

Five scientists who pioneered GLP-1-based drugs Ozempic and Wegovy receive $3 million Breakthrough Prize for life-changing contributions to diabetes and obesity treatment

Punjab constable arrested with 17.7 gms of heroin, dismissed from service

Punjab Police constable Amandeep Kaur, known for flaunting luxury cars and her uniform on Instagram, has been suspended after being arrested with 17.7 grams of heroin in Bathinda

Spurious batch of Telma H flagged, 103 other drugs fail CDSCO tests

Telma H is manufactured by Glenmark Pharmaceuticals and is prescribed for controlling high blood pressure, particularly in individuals prone to water retention or heart failure

NPPA revises ceiling prices for over 900 drug formulations from April 1

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government

NPPA to allow 1.74% hike in MRP of scheduled drugs in line with WPI rise

With this, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government in this regard

Booster shot: Mounjaro may emerge as a sweet pill for Eli Lilly in India

Analysts say the diabetes and obesity drug can be a Rs 500 crore opportunity for the firm

Piramal Pharma arm, Irish firm get UKMHRA approval for Neoatricon in UK

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for a medication used in the treatment of low blood pressure and low heart rate in children. Piramal Critical Care (PCC) has secured the commercialisation rights for Neoatricon, the first paediatric strength solution for infusion of Dopamine Hydrochloride, for the EU, the UK, and Norway markets, Piramal Pharma said in a regulatory filing. PCC would be responsible for distributing Neoatricon in these regions, it added. Developed by BrePco Biopharma, Neoatricon is an age-appropriate, ready-to-use, sterile solution for infusion of Dopamine Hydrochloride. It is available in a concentration of 1.5mg/mL in a 30 mL vial and a higher strength containing 4.5mg/mL in a 50 mL vial. Currently, there are no approved Dopamine Hydrochloride formulations specifically indicated for use in neonates, infants, or ..

Diarrhoea and viral infections spur sales of probiotics, shows data

Antidiarrheals and anti-flatulents have also grown in strong double digits - 36 per cent and 29 per cent, respectively